Baseline | 4.28 | 4.12 | | Daytime symptoms | 6 (0 to 16) | 6 (1 to 16) | | |
| Perceived disability | 5 (0 to 24) | 6 (0 to 24) | | |
| Nocturnal symptoms | 5 (0 to 12) | 6 (0 to 12) | | |
|
3 months post-intervention | 5.41 (1.34) | 5.38 (1.39) | 0.90 (−0.45 to 0.40) | Daytime symptoms | 4 (0 to 13) | 4 (0 to 16) | 0.95 | 0.0 (−1.0 to 1.0) |
| Perceived disability | 3 (0 to 19) | 3 (0 to 21) | 0.76 | 0.0 (−1.0 to 1.0) |
| Nocturnal symptoms | 3 (0 to 11) | 3 (0 to 12) | 0.50 | 0.0 (−1.0 to 1.0) |
|
12 months post-intervention | 5.45 (1.49) | 5.73 (1.28) | 0.19 (−0.14 to 0.69) | Daytime symptoms | 3 (0 to 16) | 3 (0 to 16) | 0.07 | −1.0 (−2.0 to 0.0) |
| Perceived disability | 3 (0 to 24) | 2 (0 to 32) | 0.20 | 0.0 (−1.0 to 0.0) |
| Nocturnal symptoms | 3 (0 to 12) | 2 (0 to 12) | 0.53 | 0.0 (−1.0 to 0.0) |